Figure 6From: Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab Assessment of liver and kidney functions after 227 Th-trastuzumab therapy. Measurement of urea (a), ALT (b), ALP (c), and AST (d) concentration in blood of mice with time after administration of NaCl, cold trastuzumab, 200, 400, and 600 kBq/kg of 227Th-trastuzumab.Back to article page